Label Changes for:

Sonata (Zaleplon) Capsules

April 2013

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2013

 

ADVERSE REACTIONS

Other Adverse Events Observed During the Premarketing Evaluation of Sonata
Postmarketing Reports
Hide
(web2)